203 related articles for article (PubMed ID: 26590194)
21. ALL and osteonecrosis.
Gaynon PS
Blood; 2015 Oct; 126(15):1734-5. PubMed ID: 26450951
[TBL] [Abstract][Full Text] [Related]
22. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
[TBL] [Abstract][Full Text] [Related]
23. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
[TBL] [Abstract][Full Text] [Related]
24. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract][Full Text] [Related]
25. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
[TBL] [Abstract][Full Text] [Related]
26. Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group.
Sakamoto K; Imamura T; Kihira K; Suzuki K; Ishida H; Morita H; Kanno M; Mori T; Hiramatsu H; Matsubara K; Terui K; Takahashi Y; Suenobu SI; Hasegawa D; Kosaka Y; Kato K; Moriya-Saito A; Sato A; Kawasaki H; Yumura-Yagi K; Hara J; Hori H; Horibe K
J Clin Oncol; 2018 Mar; 36(9):900-907. PubMed ID: 29360413
[TBL] [Abstract][Full Text] [Related]
27. Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia.
Advani AS; Larsen E; Laumann K; Luger SM; Liedtke M; Devidas M; Chen Z; Yin J; Foster MC; Claxton D; Coffan K; Tallman MS; Appelbaum FR; Erba H; Stone RM; Hunger SP; McNeer JL; Loh ML; Raetz E; Winick N; Carroll W; Larson RA; Stock W
Blood Adv; 2021 Jan; 5(2):504-512. PubMed ID: 33496745
[TBL] [Abstract][Full Text] [Related]
28. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.
Baldwin C; Nolan VG; Wyszynski DF; Ma QL; Sebastiani P; Embury SH; Bisbee A; Farrell J; Farrer L; Steinberg MH
Blood; 2005 Jul; 106(1):372-5. PubMed ID: 15784727
[TBL] [Abstract][Full Text] [Related]
29. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants.
Singh SK; Lupo PJ; Scheurer ME; Saxena A; Kennedy AE; Ibrahimou B; Barbieri MA; Mills KI; McCauley JL; Okcu MF; Dorak MT
Medicine (Baltimore); 2016 Nov; 95(46):e5300. PubMed ID: 27861356
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
[TBL] [Abstract][Full Text] [Related]
31. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
Liu C; Yang W; Devidas M; Cheng C; Pei D; Smith C; Carroll WL; Raetz EA; Bowman WP; Larsen EC; Maloney KW; Martin PL; Mattano LA; Winick NJ; Mardis ER; Fulton RS; Bhojwani D; Howard SC; Jeha S; Pui CH; Hunger SP; Evans WE; Loh ML; Relling MV
J Clin Oncol; 2016 Jun; 34(18):2133-40. PubMed ID: 27114598
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.
Girard P; Auquier P; Barlogis V; Contet A; Poiree M; Demeocq F; Berbis J; Herrmann I; Villes V; Sirvent N; Kanold J; Chastagner P; Chambost H; Plantaz D; Michel G
Haematologica; 2013 Jul; 98(7):1089-97. PubMed ID: 23645686
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial.
Kuhlen M; Bader P; Sauer M; Albert MH; Gruhn B; Güngör T; Kropshofer G; Lang P; Lawitschka A; Metzler M; Pentek F; Rossig C; Schlegel PG; Schrappe M; Schrum J; Schulz A; Schwinger W; von Stackelberg A; Strahm B; Suttorp M; Luettichau IT; Wößmann W; Borkhardt A; Meisel R; Poetschger U; Glogova E; Peters C
Br J Haematol; 2018 Oct; 183(1):104-109. PubMed ID: 30028016
[TBL] [Abstract][Full Text] [Related]
34. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Levien MG
Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
[No Abstract] [Full Text] [Related]
36. Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.
Mogensen SS; Schmiegelow K; Grell K; Albertsen BK; Wehner PS; Kampmann P; Frandsen TL
Haematologica; 2017 May; 102(5):e175-e178. PubMed ID: 28209659
[No Abstract] [Full Text] [Related]
37. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.
Relling MV; Yang W; Das S; Cook EH; Rosner GL; Neel M; Howard S; Ribeiro R; Sandlund JT; Pui CH; Kaste SC
J Clin Oncol; 2004 Oct; 22(19):3930-6. PubMed ID: 15459215
[TBL] [Abstract][Full Text] [Related]
38. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
39. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
van Beek RD; Bezemer DD; Meijerink JP; de Muinck Keizer-Schrama SM; Haas OA; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
Leukemia; 2006 May; 20(5):879-80. PubMed ID: 16525499
[No Abstract] [Full Text] [Related]
40. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
Ojala AE; Lanning FP; Pääkkö E; Lanning BM
Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
